181 related articles for article (PubMed ID: 25579848)
1. Investigation on the effect of polymer and starch on the tablet properties of lyophilized orally disintegrating tablet.
Liew KB; Peh KK
Arch Pharm Res; 2021 Aug; 44(8):1-10. PubMed ID: 25579848
[TBL] [Abstract][Full Text] [Related]
2. Formulation studies for mirtazapine orally disintegrating tablets.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
[TBL] [Abstract][Full Text] [Related]
3. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
Cantor SL; Khan MA; Gupta A
Drug Dev Ind Pharm; 2015; 41(7):1156-64. PubMed ID: 25000481
[TBL] [Abstract][Full Text] [Related]
4. Effect of processing methods on xylitol-starch base co-processed adjuvant for orally disintegrating tablet application.
Bin LK; Helaluddin ABM; Islam Sarker MZ; Mandal UK; Gaurav A
Pak J Pharm Sci; 2020 Mar; 33(2):551-559. PubMed ID: 32276897
[TBL] [Abstract][Full Text] [Related]
5. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
[TBL] [Abstract][Full Text] [Related]
6. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2009 Dec; 382(1-2):80-7. PubMed ID: 19686825
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
[TBL] [Abstract][Full Text] [Related]
8. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
[TBL] [Abstract][Full Text] [Related]
9. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
[TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Vural İ; Ünlü N
Pharm Dev Technol; 2018 Jun; 23(5):488-495. PubMed ID: 28368673
[TBL] [Abstract][Full Text] [Related]
11. Formulation study for orally disintegrating tablet using partly pregelatinized starch binder.
Mimura K; Kanada K; Uchida S; Yamada M; Namiki N
Chem Pharm Bull (Tokyo); 2011; 59(8):959-64. PubMed ID: 21804239
[TBL] [Abstract][Full Text] [Related]
12. Orodispersible films and tablets with prednisolone microparticles.
Brniak W; Maślak E; Jachowicz R
Eur J Pharm Sci; 2015 Jul; 75():81-90. PubMed ID: 25889975
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
Drašković M; Medarević D; Aleksić I; Parojčić J
Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
[TBL] [Abstract][Full Text] [Related]
14. Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2015 Apr; 41(4):583-93. PubMed ID: 24495273
[TBL] [Abstract][Full Text] [Related]
15. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.
Ali R; Dashevsky A; Bodmeier R
Int J Pharm; 2017 Jan; 516(1-2):3-8. PubMed ID: 27818241
[TBL] [Abstract][Full Text] [Related]
16. Microparticle surface layering through dry coating: impact of moisture content and process parameters on the properties of orally disintegrating tablets.
Alyami H; Koner J; Dahmash EZ; Bowen J; Terry D; Mohammed AR
J Pharm Pharmacol; 2017 Jul; 69(7):807-822. PubMed ID: 27696423
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of orally disintegrating tablets containing taste masked microparticles of acetaminophen.
Ikeuchi-Takahashi Y; Ito S; Itokawa A; Ota M; Onuki Y; Hidaka S; Onishi H
Pharmazie; 2020 Jan; 75(1):2-6. PubMed ID: 32033625
[TBL] [Abstract][Full Text] [Related]
18. Comparative Study Between Different Ready-Made Orally Disintegrating Platforms for the Formulation of Sumatriptan Succinate Sublingual Tablets.
Tayel SA; El Nabarawi MA; Amin MM; AbouGhaly MH
AAPS PharmSciTech; 2017 Feb; 18(2):410-423. PubMed ID: 27038484
[TBL] [Abstract][Full Text] [Related]
19. Expedited Development of Diphenhydramine Orally Disintegrating Tablet through Integrated Crystal and Particle Engineering.
Wang C; Hu S; Sun CC
Mol Pharm; 2017 Oct; 14(10):3399-3408. PubMed ID: 28825961
[TBL] [Abstract][Full Text] [Related]
20. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
